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Abstract
Background: Although maternal anaemia often stems from malaria infection during pregnancy, its effects
on foetal haemoglobin levels are not straightforward. Lower-than-expected cord haemoglobin values in
malarious versus non-malarious regions were noted by one review, which hypothesized they resulted from
foetal immune activation to maternal malaria. This study addressed this idea by examining cord
haemoglobin levels in relation to maternal malaria, anaemia, and markers of foetal immune activation.
Methods: Cord haemoglobin levels were examined in 32 malaria-infected and 58 uninfected women in
Blantyre, Malawi, in relation to maternal haemoglobin levels, malaria status, and markers of foetal
haematological status, hypoxia, and inflammation, including TNF-α, TGF-β, and ferritin. All women were
HIV-negative.
Results: Although malaria was associated with a reduction in maternal haemoglobin (10.8 g/dL vs. 12.1 g/
dL, p < 0.001), no reduction in cord haemoglobin and no significant relationship between maternal and
cord haemoglobin levels were found. Cord blood markers of haematological and hypoxic statuses did not
differ between malaria-infected and uninfected women. Maternal malaria was associated with decreased
TGF-β and increased cord ferritin, the latter of which was positively correlated with parasitaemia (r =
0.474, p = 0.009). Increased cord ferritin was associated with significantly decreased birth weight and
gestational length, although maternal and cord haemoglobin levels and malaria status had no effect on birth
outcome.
Conclusion: In this population, cord haemoglobin levels were protected from the effect of maternal
malaria. However, decreased TGF-β and elevated ferritin levels in cord blood suggest foetal immune
activation to maternal malaria, which may help explain poor birth outcomes.
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Malaria affects more than three million pregnant women
per year in developing countries, where it commonly
causes poor birth outcomes and maternal anaemia [1-3].
Brabin [4] suggested that foetal anaemia also resulted
from maternal malaria during pregnancy. In developed
countries, anaemia in newborns is rare, regardless of
maternal status, and normal neonatal haemoglobin levels
in these populations are higher than adult levels [e.g. [5]]
In addition, there appears to be little relationship between
maternal and umbilical cord haemoglobin levels, even
when mothers are anaemic [e.g., [5,6]]. For example, a
study of pregnant Turkish women found no significant
difference in mean cord haemoglobin levels of neonates
of anaemic (Hb < 10 g/dL) mothers (mean ± SEM: 16.11
± 0.39 g/dL) compared to those of non-anaemic (Hb ≥ 12
g/dL) mothers (mean ± SEM: 16.57 ± 1.35 g/dL) [5]. In
developing countries, the situation is more complex. In
non-malarious areas, babies of mothers with iron-defi-
cient anaemia have both relatively similar [e.g., [7]] and
higher [e.g., [8,9]] cord haemoglobin levels than those
reported for developed countries. In contrast, cord hae-
moglobin levels in malarious areas have been character-
ized by Brabin [4] as lower-than-expected, hypothesized
to result from foetal immune activation to maternal
malarial antigens.
In non-malarious regions, maternal anaemia may stem
chiefly from iron deficiency; higher cord haemoglobin
levels may thus reflect a response to foetal hypoxia caused
by decreased placental oxygen transport [10]. In malari-
ous regions, however, malaria infections during preg-
nancy present a second source of maternal anaemia by
increasing red blood cell destruction and decreasing eryth-
ropoiesis [3,11,12]. These effects may be mediated in part
by elevations in proinflammatory cytokines like TNF-α,
which are associated with maternal anaemia in malaria-
infected pregnancies [13,14]. Although malaria elevates
placental proinflammatory cytokine production during
pregnancy [14-16], it has not been reported to affect cord
levels [15]. However, maternal malaria may immunolog-
ically prime the foetus, as several researchers have
reported that foetal explants produce proinflammatory
cytokines upon exposure to maternal malarial antigens
[17,18].
To further address the hypothesis that cord haemoglobin
levels in malarious areas are lower than expected due to
foetal immune activation to maternal malaria, cord hae-
moglobin levels were examined in this study in malaria-
infected and uninfected women in relation to maternal
malaria status and haemoglobin levels and markers of
foetal haematological, inflammatory, and hypoxic status.
In specific, chronic foetal hypoxia was assessed via levels
of erythropoietin (Epo) [19], a hormone responsible for
red blood cell production, and corticotrophin releasing
hormone (CRH) and cortisol, two hormones that have
been hypothesized to mediate the effects of anaemia-
related hypoxia on poor birth outcomes [20]. Tumor
necrosis factor alpha (TNF-α), a pro-inflammatory
cytokine, transforming growth factor beta (TGF-β), an
anti-inflammatory cytokine, and C-reactive protein
(CRP), an acute shock protein, were assayed as markers of
inflammatory status. Haematological status was assessed
via umbilical cord levels of haemoglobin (Hb) and solu-
ble transferrin receptor (sTfR). Levels of ferritin, an iron
storage protein that is an acute phase reactant in the pres-
ence of infection, were also assayed.
As markers of interest were measured both in maternal
peripheral and umbilical cord blood, one critical issue is
whether the cord measures truly reflect foetal production
rather than placental transfer of maternally produced fac-
tors. Human data addressing this topic is limited, given
the invasive and/or complex nature of the required stud-
ies. In general, studies suggest that most substances can
cross the placenta, with the rate dependent on molecular
weight, such that those with larger molecular weights
cross slowly and those with molecular weights under 500
daltons quite rapidly [21]. Erythropoietin, a protein with
a large molecular weight, is undetectable on the placental
side opposite its origin [22], and it is likely that high
molecular weight sequesters other large molecules like fer-
ritin [23] on the side of the placenta on which they were
produced. A placental perfusion study of inflammatory
cytokine transfer suggested that TNF-α, a cytokine meas-
ured in this study, does not readily cross from the mater-
nal to the foetal side of the placenta, although IL-6, which
was not assayed in this study, appears to cross the placenta
bidirectionally [24]. CRP is also unlikely to cross the pla-
centa [25]. Cortisol may cross the placenta in its active
form, but foetal exposure to maternal cortisol is normally
limited by the conversion of cortisol to cortisone, its inac-
tive metabolite, by placental 11β-hydroxysteroid dehy-
drogenase [26].
Methods
Subjects
Ninety pregnant women pre-labor or in the latent phase
of labor attending the Labour Ward, Queen Elizabeth
Central Hospital, Blantyre, Malawi, were recruited from
February to October 2002 as part of a prospective cohort
study investigating the impact of maternal malaria on HIV
vertical transmission [27]. All women with positive
peripheral malaria blood smears in the larger study were
enrolled, along with the next two sequential uninfected
women. Women were excluded from this study if they had
HIV, preeclampsia, or multiple gestations.Page 2 of 8
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level, maternal and paternal occupations, and house con-
struction), health (antenatal clinic attendance and iron
tablets usage) and anthropometric (height, weight, and
mid-upper arm circumference (MUAC)) data were col-
lected. Neonatal anthropometrics (head, abdominal, and
arm circumferences, recumbent length, and weight) were
evaluated within the first 24 hours after birth. Gestational
age was determined by the New Ballard Score [28].
Sampling procedure
Maternal peripheral blood samples were taken at recruit-
ment, and cord and placental samples were collected at
delivery. Thick blood films were prepared from these sam-
ples for malaria microscopy. Placental blood was col-
lected into EDTA by incising the cleaned maternal surface
of the placenta and aspirating blood welling from the inci-
sion with a sterile pipette. Samples were separated within
one hour, and plasma was stored at -70°C. Placental biop-
sies from a pericentric area (approximately 1 cm from the
cord on the maternal side) were placed into 10% neutral
buffered formalin to be used for placental malaria
histopathology.
Malaria status
Thick blood films were air-dried and Field's stained. Plas-
modium falciparum malaria parasitaemia per µl was deter-
mined by counting parasites per 200 leukocytes, assuming
6000 leukocytes per µl [29]. Placental malaria histopa-
thology was determined by SJR as described [13]; stage of
infection and degree of malaria pigment in placental
monocytes and fibrin were evaluated to determine disease
severity [13]. For the purposes of data analysis, malaria
infection was defined as either maternal (any parasites on
maternal peripheral thick blood film) or placental (any
parasites on placental thick blood film or
histopathology).
HIV status
All subjects were consented and received HIV pre-test and
post-test counseling before the onset of active labor. HIV
status was determined by Serocard rapid test for HIV-1
and 2 (Trinity Biotech, Wicklow, Ireland) and Determine
HIV1/2 (Abbott Diagnostics, Abbott Park, Illinois, USA);
disagreement between tests was settled by HIV-SPOT
ELISA (Genelabs Diagnostics, Singapore).
Markers of haematological status
Haemoglobin (Hb) concentration were measured in
peripheral and cord blood samples using a Hemocue®
haemoglobinometer (HemoCue AB, Ängelholm, Swe-
den); some results were not available as samples clotted.
Maternal peripheral and cord plasma soluble transferrin
receptor (sTfR) and ferritin were assayed by enzyme-
linked immunosorbent assay (ELISA) kits according to
manufacturer's instructions (Ramco Laboratories, Staf-
ford, TX; and IBL, Hamburg, Germany; respectively). Data
were analysed in Microsoft Excel using a log-log standard
curve. Limits of detection were as follows: 1 µg/ml (sTfR)
and 0.59 ng/ml (ferritin).
Markers of inflammation
Maternal peripheral, placental and cord plasma tumor
necrosis factor-α (TNF-α) and transforming growth factor-
β (TGF-β) and maternal peripheral and cord plasma C
reactive protein (CRP) levels were also assayed by ELISA
(R&D Systems, Minneapolis, MN, USA). Color was devel-
oped by SigmaFast o-phenylenediamine dihydrochloride
tablets (Sigma, St. Louis, MO, USA). Data were analysed
as described above. Limits of detection were as follows: 4
pg/ml (TNF-α), 13 pg/ml (TGF-β), and 1 µg/ml (CRP).
Markers of chronic foetal hypoxia
Because scalp blood gas analysis, the most accurate means
of assessing foetal hypoxia, was not feasible in the study
setting, other proxies for chronic foetal hypoxia were
measured: erythropoietin (Epo) [19], and cortisol and
corticotrophin-releasing hormone (CRH) [20]. Maternal
peripheral, placental, and cord plasma erythropoietin
(Epo) levels were assayed by ELISA according to manufac-
turer's instructions (IBL, Hamburg, Germany). Placental
and cord cortisol (CRT) and placental CRH were deter-
mined by ELISA as well (cortisol: R&D Systems, Minneap-
olis, MN, USA; CRH: Phoenix Pharmaceuticals, Belmont,
CA, USA, respectively). Data were analysed as described
above. Limits of detection were as follows: 0.4 mU/mL
(EPO), 0.16 ng/ml (cortisol), and 0.19 ng/ml (CRH).
Ethical approval
This study was approved by the College of Medicine
Research Committee, University of Malawi, and the Insti-
tutional Review Boards of the University of Michigan and
the University of North Carolina.
Statistical analyses
Data were entered in MS-Access and analyses were per-
formed using SPSS v.10 and Intercooled Stata 8.0. Skewed
data were log or (log+1) transformed before certain anal-
yses. Maternal characteristics in malaria-infected and
uninfected women (Table 2) were compared by t-tests
(continuous variables) and chi-squared tests (dichoto-
mous variables). Mann-Whitney U tests were used to com-
pare maternal and cord characteristics in malaria-infected
and uninfected women (Tables 3 and 4). Bonferroni's
method was used as a more conservative measure of sig-
nificance for multiple comparisons [30]; p values reported
reflect pre-adjustment values. The 5% significance level
was used to determine significance.Page 3 of 8
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Study population
Of the 90 study participants, 29 had maternal peripheral
malaria infections, 32 had placental malaria infections,
and 42 had infections in one or both compartments. No
cord blood malaria was identified in this study. Table 1
cross-references malaria infections by compartment and
diagnostic method.
Table 2 shows the characteristics of study enrollees classi-
fied by maternal peripheral malaria. All women were HIV
negative. Women with and without peripheral malaria
infections were similar in terms of age and anthropomet-
ric measures. However, malaria-infected women were
younger, of lower parity, and tended to have fewer ante-
natal clinic visits (Table 2). Socioeconomic status, as
measured by educational level, house construction, and
employment status, did not differ between the groups
(Table 2). When women were alternatively classified by
placental malaria status, there were again no significant
differences in study participant characteristics (data not
shown). However, when reclassified according to malaria
infection in any compartment (maternal and/or placen-
tal), malaria-infected women had significantly lower BMI
(23.4 ± 4.0 vs. 24.8 ± 2.4; p = 0.02) and fewer antenatal
clinic visits (4.8 ± 1.8 vs. 5.7 ± 2.5; p = 0.045); no other
characteristics differed between the groups (data not
shown).
Data on the effects of malaria on maternal and foetal
markers of haematological status, inflammation, and
chronic hypoxia are presented in two tables: Table 3
presents the effects of maternal peripheral malaria on the
markers, and Table 4 presents the effects of placental
malaria.
Table 1: Malaria infections by compartment and diagnostic method
Malaria infection in any compartment Compartment Total 
cases
Placental diagnostic method (# positive cases) Total 
cases
Present 42 Maternal malaria only 10
Maternal and placental malaria 19 Thick smear 1
Histopathology 5
Both 13
Placental malaria only 13 Thick smear 0
Histopathology 4
Both 9
Absent 48
Total 90
Table 2: Maternal characteristics in women with and without maternal peripheral malaria infection
Malaria-infected mean ± STD (n) 
total n: 29
Malaria-uninfected mean ± STD (n) 
total n: 61
Age 20.9 ± 3.2 (29) 22.8 ± 5.2 (61) t = 2.11, p = 0.038
Parity 1.5 ± 0.9 (29) 2.1 ± 1.5 (61) t = 2.26, p = 0.026
Number of antenatal clinic visits 4.7 ± 2.0 (29) 5.6 ± 2.3 (61) t = 1.78, p = 0.079
Maternal weight (kg) 56.4 ± 8.4 (29) 59.0 ± 7.4 (61) t = 1.51, p = 0.136
Maternal height (cm) 154.6 ± 6.0 (29) 155.3 ± 4.9 (61) t = 0.60, p = 0.552
BMI 23.6 ± 2.9 (29) 24.4 ± 2.6 (61) t = 1.44, p = 0.153
MUAC (cm) 23.7 ± 2.9 (16) 24.6 ± 2.2 (38) t = 1.33, p = 0.190
Took iron supplements 86% (25/29) 93% (55/59) χ2 = 1.16, p = 0.282
Took antimalarial tablets 83% (24/29) 95% (55/58) χ2 = 3.37, p = 0.066
Slept under mosquito net 17% (5/29) 31% (18/58) χ2 = 1.89, p = 0.169
8th grade education or less 48% (14/29) 52% (32/61) χ2 = 0.14, p = 0.711
Lived in a mud-walled house 77% (20/26) 69% (35/51) χ2 = 0.58, p = 0.446
Mother self or formally employed 21% (6/29) 20% (12/61) χ2 = 0.01, p = 0.910
Father self or formally employed 92% (23/25) 86% (44/51) χ2 = 0.53, p = 0.468Page 4 of 8
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markedly between women and neonates. Compared to
their uninfected counterparts, women characterized by
any of the three definitions of malaria infection tended to
have significantly lower maternal Hb concentrations
(maternal: Table 3; placental: p = 0.017; any: p < 0.001).
Unlike maternal haematological status, neonatal charac-
teristics were protected from the effects of maternal and
placental malaria. Mean cord Hb levels did not differ
between malaria-infected and uninfected women (Tables
3 and 4). In addition, malarial disease severity, including
peripheral and placental parasite density, stage of disease,
and deposition of fibrin and malaria pigment in placental
monocytes, had no effect on neonatal Hb (data not
shown). Neither cord nor maternal sTfR levels were
affected by malaria infection in this study (Tables 3 and
4).
Markers of inflammation were also altered in malaria-
infected women, who had significantly elevated CRP and
TNF-α (maternal: Table 3; placental: CRP (p < 0.001),
TNF-α (p = 0.022); any: CRP (p < 0.001), TNF-α (p =
0.004)) and lower TGF-β, although this result was not sig-
nificant after Bonferroni's adjustment (maternal: Table 3;
placental: NS; any: p = 0.010). There was no effect of
maternal malaria on foetal TNF-α or CRP (Table 3). TGF-
β was significantly decreased in the cord blood of
neonates with peripheral malaria-infected mothers,
Table 3: Mann-Whitney U test of effect of maternal peripheral malaria on maternal and neonatal haematological and inflammatory 
status
Infected median (IQRa) n (total n: 29) Uninfected median (IQR) n (total n: 61) p
Maternal
Hb (g/dL) 10.8 (10.1 – 11.2) 29 12.1 (11.1 – 13.1)61 <0.001b
sTfR (µg/ml) 5.7 (3.8 – 9.2) 29 6.6 (4.9 – 9.7) 61 0.460
ferritin (ng/ml) 95.3 (42.3 – 180.8) 29 16.5 (6.0 – 33.1) 61 0.001b
TNF-α (pg/ml) 22.9 (7.9 – 72.1) 29 1.8 (0.0 – 24.4) 61 0.001b
TGF-β (ng/ml) 11.0 (6.0 – 15.9) 29 15.5 (9.6 – 18.3) 55 0.027
CRP (µg/ml) 85.0 (59.2 – 195.4) 29 7.6 (2.8 – 26.2) 61 <0.001b
Epo (mU/L) 60.6 (41.0 – 98.5) 29 32.7 (21.6 – 52.6) 61 0.001b
Cord
Hb (g/dL) 15.9 (14.5 – 16.9) 22 15.6 (14.5 – 17.1) 48 0.849
sTfR (µg/ml) 6.7 (4.8 – 9.9) 29 7.8 (4.9 – 9.7) 60 0.430
ferritin (ng/ml) 135.5 (66.7 – 276.3) 29 99.0 (39.4 – 158.7) 60 0.040
TNF-α (pg/ml) 1.0 (0.0 – 8.4) 28 2.7 (0.0 – 16.6) 59 0.371
TGF-β (ng/ml) 17.8 (13.5 – 24.0) 15 27.7 (20.7 – 31.9) 32 0.019
CRP (µg/ml) 1.5 (0.7 – 1.7) 28 1.0 (0.0 – 1.6) 61 0.169
Epo (mU/L) 27.1 (13.4 – 58.9) 29 25.8 (12.5 – 39.1) 61 0.641
aIQR: Inter-quartile range
b Significant after Bonferroni's adjustment for multiple comparisons.
Table 4: Mann-Whitney U test of effect of placental malaria on markers of neonatal haematological, inflammatory, and hypoxic status
Infected median (IQRa) n (total n: 32) Uninfected median (IQR) n (total n: 58)
Cord
Hb (g/dL) 15.4 (13.7 – 16.8) 25 16.0 (15.0 – 17.1) 45 p = 0.128
sTfR (µg/ml) 6.7 (5.1 – 9.9) 32 7.7 (4.3 – 9.6) 58 p = 0.765
ferritin (ng/ml) 129.0 (61.9 – 248.6) 32 101.0 (41.2 – 210.8) 57 p = 0.184
TNF-α (pg/ml) 1.7 (0.0 – 5.6) 30 2.7 (0.0 – 15.9) 57 p = 0.552
TGF-β (ng/ml) 19.5 (15.6 – 30.3) 16 26.8 (17.9 – 31.8) 31 p = 0.080
CRP (µg/ml) 1.5 (0.7 – 1.6) 31 1.0 (0.0–1.6) 58 p = 0.289
Epo (mU/L) 25.4 (13.4 – 58.1) 32 27.5 (12.5 – 45.1) 58 p = 0.940
Cortisol (µg/ml) 421.0 (283.5 – 538.5) 32 511.0 (324.0 – 677.5) 53 p = 0.425
Placenta
Cortisol (µg/ml) 191.0 (155.5 – 251.0) 29 172.0 (132.0 – 248.5) 53 p = 0.357
CRH (pg/ml) 90.0 (42.5 – 126.4) 24 72.3 (41.5 – 116.3) 43 p = 0.421
aIQR: Inter-quartile rangePage 5 of 8
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adjustment (Table 3). Among babies of malaria-infected
women, neither increased maternal or placental parasite
density nor markers of disease severity were associated
with increases in measures of neonatal inflammation
(data not shown). However, elevated maternal CRP in
women with peripheral malaria infections was associated
with significantly increased cord CRP (r = 0.48, p = 0.010)
and decreased cord TGF-β (r = -0.60, p = 0.019), suggest-
ing an association between maternal and foetal immune
activation.
Malaria-infected women had significantly higher ferritin
levels than uninfected women (maternal: Table 3; placen-
tal: p < 0.001; any: p < 0.001). Cord ferritin was signifi-
cantly increased in the cord blood of neonates with
peripheral malaria-infected mothers, although this result
was not significant after Bonferroni's adjustment (Table
2). In addition, cord ferritin was correlated with increas-
ing maternal parasite load in malaria-infected women (r =
0.474, p = 0.009). The notion that ferritin levels in this
group reflected malaria-related inflammation is further
supported by the inverse correlation between cord ferritin
and cord TGF-β (r = -.593, p = 0.020). Additionally, prim-
igravids with placental malaria infections, who tend to
experience its inflammatory effects more acutely than
multigravids, had significantly higher cord ferritin levels
than did multigravid malaria-infected women (p =
0.021). However, despite the indications of immune acti-
vation in neonates of malaria-infected women, none of
the cord immune markers were correlated with cord Hb or
sTfR (data not shown).
Although women characterized by any of the three defini-
tions of malaria infection tended to have significantly
higher Epo levels than uninfected women (maternal:
Table 3; placental: NS; any: p = 0.004), none of the proxies
for foetal hypoxia examined in the study (cord Epo, pla-
cental and cord cortisol, and placental CRH) were
increased in the neonates of malaria-infected women
(Tables 3 and 4). Among malaria-infected women,
increased maternal and placental parasitaemia and mark-
ers of disease severity were also not associated with
increased levels of these factors (data not shown).
Neonatal haematological, immune and hypoxic markers
were then examined in relation to poor birth outcomes
that have been associated with maternal malaria, particu-
larly low birthweight and preterm delivery. In this study,
neither the presence nor the severity of maternal or pla-
cental malaria was associated with decreased birthweight
or gestational age, perhaps due to the limited sample size
(data not shown). Unsurprisingly, therefore, neither
decreased maternal nor cord Hb was significantly associ-
ated with poorer birth outcomes in malaria-infected
women (data not shown), although cord sTfR levels,
which were not different between neonates of malaria-
infected and uninfected women (Tables 3 and 4), were
inversely associated with birthweight in women with
maternal, but not placental, malaria (r = -.452, p = 0.014).
In neonates of women with both maternal and placental
malaria, elevated cord ferritin was correlated with lower
birthweights (maternal: r = -0.427, p = 0.021; placental: r
= -0.374, p = 0.035), and in those of women with mater-
nal malaria, with shorter gestations as well (r = -0.432, p
= 0.024). This association was not due to inflammation
alone, since there was no association with cord CRP or
TGF-β, nor to foetal haematopoiesis alone, since there was
no association with cord Epo (data not shown). However,
the data suggest that a combination of the haematological
and inflammatory processes might be associated with
poor birth outcomes commonly found following malaria
infection during pregnancy.
Discussion
In this study, the haematological status of neonates of
mothers with malaria parasitaemia at delivery was not sig-
nificantly impacted. Despite the effect of malaria on
maternal Hb, which was expectedly lower, neonatal Hb
levels were not decreased in the cord blood of malaria-
infected compared to uninfected women. In addition,
cord Hb values were not correlated to maternal Hb con-
centration in either group or severity of malaria, as
described in the Results section. Although the sample size
was relatively small, these results resemble more closely
the results from Western studies, which tend to find unaf-
fected cord values, than the studies of malaria- and non-
malaria-exposed mother-neonate pairs in developing
countries, as reviewed by Brabin [4]. It is unclear why, but
the high cord haemoglobin levels observed in this study
may relate to the high rates of antimalarial usage and iron
supplementation in Malawian women (Table 2), which
might provide a protective effect. The maintenance of cord
Hb levels despite the presence of maternal anaemia and
malaria suggests that the foetus has developed mecha-
nisms to preferentially obtain sufficient iron and produce
adequate amounts of red cells. Iron is transported unidi-
rectionally from mother to foetus across a concentration
gradient [31], and thus stores should be preferentially pre-
served in the foetus.
Ferritin is an iron storage protein that is an acute phase
reactant in the presence of infection. While cord ferritin
decreases in foetuses of anaemic mothers without
malaria, it appears to increase in foetuses of mothers with
increasing parasitaemia. Increased ferritin in the presence
of inflammation has been suggested to reflect an evolu-
tionary strategy by which the body removes bioavailable
iron from the presence of parasites [32]. In foetuses of
mothers with malaria, it may have an additional function:Page 6 of 8
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ingly, in this study, elevated cord ferritin levels best pre-
dicted poor birth outcomes, including shorter gestation
and lower birth weight. It is unclear why this association
was found, particularly since no association was found in
this study between birth outcomes and malaria infection
or maternal anaemia, two well-established risk factors.
This suggests that increased cord ferritin might be a result
of the same foetal stresses that cause poor birth outcomes.
Many researchers have assumed that foetal hypoxia, rather
than inflammation, mediates the effect of malaria and
maternal anaemia on birth outcomes, particularly low
birth weight. Despite the induction of foetal hypoxia by
maternal anaemia [20,33] and the decrease in umbilical
blood flow in pregnant women with malaria [34], it has
not been rigorously demonstrated that chronic low-grade
hypoxia causes poor birth outcomes, and it is unclear how
severe anaemia must be to induce foetal hypoxia. Foetal
hypoxia is difficult to quantify in nonwestern settings. In
developed countries, blood gases are collected as soon as
the foetal scalp is discernable exiting the birth canal. This
technique is not feasible in hospitals in developing coun-
tries, but several biochemical measures in cord blood may
offer proxies for foetal hypoxia. In particular, Epo, the
hormone primarily responsible for regulation of erythro-
poiesis, is stimulated by both anaemia and hypoxia [35]
and is a good marker of chronic foetal hypoxia [19,36]
because Epo does not cross the placenta. Several studies
have reported both adequate [37-39] and inadequate
[40,41] Epo production for the level of anaemia in
malaria-infected children and adults, and this question
requires further investigation. In this study, maternal Epo
was elevated in malaria-infected women (Table 3), but
cord Epo levels were not affected by either maternal or
placental malaria infections (Tables 3 and 4).
Allen [20] hypothesized that foetal stress hormones (cor-
tisol and CRH) might mediate the link between maternal
anaemia and poor birth outcomes, via the effect of anae-
mia-induced foetal hypoxia on these hormones. In this
study, cord cortisol and placental cortisol and CRH were
neither elevated in association with maternal malaria
infection nor associated with poor birth outcomes. This
may reflect the inadequacy of these factors as markers for
chronic foetal hypoxia, either in general or in cord blood,
or may simply be a result of the small sample size. On the
other hand, hypoxia in the foetus may be so fleeting, as
the foetus downregulates its growth in relation to availa-
ble oxygen levels, that it does not trigger lasting detectable
markers. This response is seen in sheep, where pregnant
females with experimentally-induced anaemia evince a
compensatory decrease in foetal growth but no actual evi-
dence of hypoxia [42].
Conclusion
In summary, cord haemoglobin levels were unchanged by
maternal malaria and anaemia during pregnancy in this
population. However, maternal parasitaemia induced a
foetal inflammatory response, specifically lower TGF-β
and higher ferritin levels. Elevated cord ferritin in turn was
associated with lower birthweights and shorter gestations.
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